$450 million East Coast flagship cGMP facility will increase Ac-225 production capacity twentyfold, supporting the next generation of cancer therapies 

PHILADELPHIA, May 6, 2026 /PRNewswire/ -- TerraPower Isotopes® (TPI), part of TerraPower, a nuclear innovation company that advances transformative technologies across both energy and healthcare, broke ground today on its flagship Bellwether Laboratory—a 250,000-square-foot actinium-225 (Ac-225) manufacturing facility located in the Bellwether District of Philadelphia. The groundbreaking marks the next major milestone in TPI's journey to establish a state-of-the-art East Coast manufacturing presence dedicated to the production of one of the rarest and most medically promising isotopes to support the development of targeted alpha therapy and precision medicine.

Recommended for you